TRAVASOL 8.5% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Mar 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRAVASOL 8.5% W/ ELECTROLYTES is a sterile injectable solution containing amino acids, electrolytes (magnesium, potassium, sodium), and chloride designed for parenteral nutrition support. It provides essential amino acids and electrolyte balance for patients unable to maintain adequate nutrition through oral or enteral routes. This formulation supports protein synthesis and metabolic homeostasis in critically ill, post-operative, and nutritionally compromised patients.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100); team focus likely shifting to cost management, channel strategy, and retention of institutional contracts.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TRAVASOL in a LOE-approaching lifecycle offers limited career trajectory in innovation but strong opportunity to build expertise in institutional sales, managed care negotiation, and cost-containment strategy. The mature, generic-threatened market environment requires professionals skilled in channel optimization and competitive pricing rather than product launches or clinical development.
Hospital/IDN Account Manager
Worked on TRAVASOL 8.5% W/ ELECTROLYTES at Baxter? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.